Lentiviral (HIV)-based RNA interference screen in human B-cell receptor regulatory networks reveals MCL1-induced

Antonio Ruiz-Vela1, Mohit Aggarwal, Paloma de la Cueva

  • 1Lymphoma Group, Department of Molecular Pathology, Biotechnology Program, Spanish National Cancer Centre, Madrid, Spain. antonio.ruizvela@universia.es

Blood
|November 23, 2007
PubMed

Insights

Aberrant inhibition of B-cell receptor (BCR) signaling promotes lymphoma development. Targeting MCL1, a key survival protein, restores BCR-induced cell death, offering a potential therapeutic strategy for B-cell lymphomas.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Aberrant inhibition of B-cell receptor (BCR)-induced programmed cell death is linked to human auto-reactive B-cell lymphomas.
  • Understanding the oncogenic mechanisms driving these lymphomas is crucial for developing effective therapies.

Purpose of the Study:

  • To identify oncogenic mechanisms that inhibit BCR-induced clonal deletion pathways in human B-cell lymphomas.
  • To investigate the role of MCL1 in B-cell lymphoma survival and transformation.

Main Methods:

  • Utilized loss-of-function, genomic, and bioinformatics approaches.
  • Conducted an HIV-based RNA interference screen to identify key survival molecules.
  • Performed genome-wide gene expression profiling of MCL1-overexpressing B-cell lymphomas.

Main Results:

  • Identified MCL1 as a critical survival molecule in BCR signaling; its loss sensitized lymphomas to BCR-induced cell death.
  • MCL1 overexpression inhibited programmed cell death upon BCR stimulation.
  • Bioinformatic analysis revealed MCL1-induced reprogramming of oncoproteins within beta-catenin-T-cell factor signaling pathways.

Conclusions:

  • MCL1 is an aberrantly expressed oncoprotein in follicular lymphomas.
  • MCL1 plays a key role in lymphoma cell survival and transformation.
  • MCL1 represents a significant therapeutic target for B-cell lymphomas.

Related Concept Videos

Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...